Exclusive

Publication

Byline

Location

US Patent Issued to AHV International on Aug. 18 for "Compositions for disrupting biofilm formation and for treating biofilm-related disorders" (Dutch Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,612, issued on Aug. 18, was assigned to AHV International B.V. (Zwolle, Netherlands). "Compositions for disrupting biofilm formation and fo... Read More


US Patent Issued to NOMIO NUTRITION on Aug. 18 for "Methods for improving physical exercise performance" (Swedish Inventor)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,613, issued on Aug. 18, was assigned to NOMIO NUTRITION AB (Stockholm). "Methods for improving physical exercise performance" was invented ... Read More


US Patent Issued to Somerset Therapeutics on Aug. 18 for "Ready-to-use ascorbic acid compound compositions" (New Jersey Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,614, issued on Aug. 18, was assigned to Somerset Therapeutics LLC (Somerset, N.J.). "Ready-to-use ascorbic acid compound compositions" was ... Read More


US Patent Issued to Vicore Pharma on Aug. 18 for "Selective angiotensin II receptor ligands" (Swedish Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,615, issued on Aug. 18, was assigned to Vicore Pharma AB (Stockholm). "Selective angiotensin II receptor ligands" was invented by Tomas Fex... Read More


US Patent Issued to The Regents of the University of California on Aug. 18 for "Compositions and methods of treating age-related retinal dysfunction" (California Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,616, issued on Aug. 18, was assigned to The Regents of the University of California (Oakland, Calif.). "Compositions and methods of treatin... Read More


US Patent Issued to Deciphera Pharmaceuticals on Aug. 18 for "Amorphous kinase inhibitor formulations and methods of use thereof" (Oregon, Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,617, issued on Aug. 18, was assigned to Deciphera Pharmaceuticals LLC (Waltham, Mass.). "Amorphous kinase inhibitor formulations and method... Read More


US Patent Issued to HANMI PHARM. on Aug. 18 for "Pharmaceutical composite formulation comprising proton pump inhibitor and antacid, and method for preparing same" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,618, issued on Aug. 18, was assigned to HANMI PHARM. Co. LTD. (Hwaseong-si, South Korea). "Pharmaceutical composite formulation comprising ... Read More


US Patent Issued to Prilenia Neurotherapeutics on Aug. 18 for "Use of pridopidine for treating anxiety and depression" (Israeli Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,619, issued on Aug. 18, was assigned to Prilenia Neurotherapeutics Ltd. (Yakum, Israel). "Use of pridopidine for treating anxiety and depre... Read More


US Patent Issued to Convert Pharmaceuticals on Aug. 18 for "Prodrugs and medical uses thereof" (Belgian Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,620, issued on Aug. 18, was assigned to Convert Pharmaceuticals S.A. (Liege, Belgium). "Prodrugs and medical uses thereof" was invented by ... Read More


US Patent Issued to Albert Einstein College of Medicine on Aug. 18 for "Small molecule BAX inhibitors and uses thereof" (Canadian, American Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,621, issued on Aug. 18, was assigned to Albert Einstein College of Medicine (Bronx, N.Y.). "Small molecule BAX inhibitors and uses thereof"... Read More